Articles From: Teva Announces U.S. Supreme Court Decision to Reverse Federal Circuit Court’s Judgment on COPAXONE® 20 mg/mL Case and Remand for Further Review to Texas Instruments board declares quarterly dividend


2015/1/20
Teva Pharmaceutical Industries Ltd.
Sign-up for Teva Announces U.S. Supreme Court Decision to Reverse Federal Circuit Court’s Judgment on COPAXONE® 20 mg/mL Case and Remand for Further Review investment picks
2015/2/17
Teva Pharmaceutical Industries Ltd.
Sign-up for Teva Bolsters Injectable Portfolio with Launch of Generic Lovenox® and Generic Zyvox® in the United States investment picks
2015/2/10
In accordance with Section 203.01 of the New York Stock Exchange Listed Company Manual, Teva Pharmaceutical Industries Ltd.
Sign-up for Teva Files 2014 Annual Report on Form 20-F investment picks
2015/1/6
Teva Pharmaceutical Industries Ltd.
Sign-up for Teva Launches Generic Diovan® in the United States investment picks
2015/2/5
By Michael Calia Teva Pharmaceuticals Industries Ltd.
Sign-up for Teva Pharmaceuticals Profit Rises as Costs Decline investment picks
2014/12/11
Teva Pharmaceutical Industries Ltd.
Sign-up for Teva Provides 2015 Business Outlook investment picks
2015/1/26
Teva Pharmaceutical Industries Ltd.
Sign-up for Teva Receives FDA Approval for First Generic Nexium® Delayed-Release Capsules in the United States investment picks
2014/12/4
Teva Pharmaceutical Industries Ltd., (NYSE:TEVA) today announced that it has received a positive outcome in the decentralized procedure for its new, three-times-a-week COPAXONE ® (glatiramer acetate) 40 mg/ml formulation for the treatment of adults with relapsing forms of multiple sclerosis (RMS). The outcome follows a Positive Assessment Report from the United Kingdom, the Reference Member State’s Medicines and Healthcare Products Regulatory Agency (MHRA), and all Concerned Member States (CMS) in Europe who were involved in the procedure.
Sign-up for Teva Receives Positive Outcome in Europe for Three-Times-a-Week COPAXONE® (Glatiramer Acetate) 40 mg/ml for the Treatment of Relapsing Forms of Multiple Sclerosis (RMS) investment picks
2015/2/5
Teva Pharmaceutical Industries Ltd.
Sign-up for Teva Reports Fourth Quarter and Full Year 2014 Results investment picks
2015/2/5
The Board of Directors of Teva Pharmaceutical Industries Ltd.
Sign-up for Teva Thanks Dr. Phillip Frost for Board Service investment picks
2015/2/17
By Angela Chen Teva Pharmaceutical Industries Ltd.
Sign-up for Teva to Distribute Eagle Pharmaceutical's Cancer Drug in U.S. investment picks
2014/12/1
Teva Pharmaceutical Industries Ltd.
Sign-up for Teva to Host 2015 Business Outlook Conference Call and Webcast on December 11, 2014 investment picks
2015/1/8
Teva Pharmaceutical Industries Ltd.
Sign-up for Teva to Present at the 33rd Annual J.P. Morgan Healthcare Conference investment picks
2014/12/22
Teva Pharmaceutical Industries Ltd.
Sign-up for Teva to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference investment picks
2015/2/20
Teva Pharmaceutical Industries Ltd., (NYSE:TEVA) today announced that four company-sponsored abstracts will be presented at the 2015 Annual Meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI) in Houston, Texas.
Sign-up for Teva to Present New Respiratory Data at 2015 Annual Meeting of the American Academy of Allergy, Asthma and Immunology investment picks
2015/1/15
Teva Pharmaceutical Industries Ltd.
Sign-up for Teva to Report Fourth Quarter 2014 Financial Results on February 5, 2015 investment picks
2015/1/26
Teva Pharmaceutical Industries (TEVA) said on Monday that the U.S. Food and Drug Administration approved its generic equivalent to AstraZeneca's (AZN) blockbuster heartburn treatment Nexium.
Sign-up for Teva's generic version of AstraZeneca's Nexium gets FDA approval investment picks
2015/1/28
With the new year upon us, Texas.gov is a great way to meet your resolution of being more organized.
Sign-up for Texas - Get a Jumpstart on Being Organized in 2015 investment picks
2015/2/11
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1174436&ProfileId=051205&sourceType=1 ROSELAND, NJ --
Sign-up for Texas Added 25,800 Private Sector Jobs in January, According to ADP Regional Employment Report(R) investment picks
2014/12/10
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1163976&ProfileId=051205&sourceType=1 ROSELAND, NJ --
Sign-up for Texas Added 29,700 Private Sector Jobs in November, According to ADP Regional Employment Report(R) investment picks
2015/1/14
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1168914&ProfileId=051205&sourceType=1 ROSELAND, NJ --
Sign-up for Texas Added 31,100 Private Sector Jobs in December, According to ADP Regional Employment Report(R) investment picks
2014/12/3
By Philip van Doorn, MarketWatch The Lone Star state, home to the energy industry, suffers collateral damage Oil companies aren't the only ones taking a pounding from the tumble in crude prices.
Sign-up for Texas bank stocks dinged by drop in oil prices investment picks
2014/12/3
For comparison, the FDIC said in its quarterly banking profile that the aggregate third-quarter return on assets for all U.S. banks was 1.02% and the return on average equity was 9.04%. The aggregate ratio of noncurrent loans to total loans was 2.11%. To test reserve adequacy, it is best to compare loan charge-off rates to reserve coverage.
Sign-up for Texas bank stocks dinged by drop in oil prices -2- investment picks
2015/1/21
DALLAS, Jan.
Sign-up for Texas Capital Bancshares, Inc. Announces Operating Results for 2014 investment picks
2015/1/8
DALLAS, Jan.
Sign-up for Texas Capital Bancshares, Inc. Announces Q4 2014 Earnings Call investment picks
2015/2/17
DALLAS, Feb.
Sign-up for Texas Capital Bancshares, Inc. Announces Quarterly Dividend for Preferred Stock investment picks
2014/12/1
DALLAS, Dec.
Sign-up for Texas Capital Bank Ranks 11th in Dallas Morning News Top 100 Places to Work investment picks
2015/1/9
DALLAS, Jan.
Sign-up for Texas Capital Bank Ranks in the Top 20 on the 2015 Forbes Best Banks in America List investment picks
2015/1/27
Cigna (NYSE: CI) and North Texas CIN, Inc. (TXCIN) have launched a collaborative care initiative to improve patient access to health care, enhance care coordination , and achieve the goal of improved health , affordability and patient experience .
Sign-up for Texas Clinically Integrated Network and Cigna Start Collaborative Care Program to Improve Health and Lower Costs in North Texas investment picks
2015/1/15
DALLAS , Jan.
Sign-up for Texas Instruments board declares quarterly dividend investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Teva Announces U.S. Supreme Court Decision to Reverse Federal Circuit Court’s Judgment on COPAXONE® 20 mg/mL Case and Remand for Further Review to Texas Instruments board declares quarterly dividend
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent